Sharon M. Moe

Active 1999–2024

113
Papers
20,054
Citations
68
h-index
109
i10-index

Citations

Citations per year for Sharon M. Moe1986: 1 citations2001: 4 citations2002: 12 citations2003: 41 citations2004: 104 citations2005: 142 citations2006: 122 citations2007: 190 citations2008: 207 citations2009: 162 citations2010: 163 citations2011: 136 citations2012: 147 citations2013: 162 citations2014: 124 citations2015: 121 citations2016: 107 citations2017: 128 citations2018: 107 citations2019: 545 citations2020: 542 citations2021: 509 citations2022: 343 citations2023: 281 citations2024: 407 citations2025: 168 citations2026: 2 citations1987–2000: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,375 citing papers, 25% of this breakdownUnited Kingdom: 355 citing papers, 6.4% of this breakdownChina: 336 citing papers, 6.1% of this breakdownGermany: 300 citing papers, 5.4% of this breakdownItaly: 286 citing papers, 5.2% of this breakdownFrance: 256 citing papers, 4.6% of this breakdownSpain: 217 citing papers, 3.9% of this breakdownJapan: 204 citing papers, 3.7% of this breakdownNetherlands: 180 citing papers, 3.3% of this breakdownCanada: 179 citing papers, 3.3% of this breakdownAustralia: 173 citing papers, 3.1% of this breakdownBelgium: 146 citing papers, 2.7% of this breakdown
0%25%Other 27.3%

Fields

  • Medicine82.6%
  • Biochemistry, Genetics and Molecular Biology10%
  • Nursing2.4%
  • Immunology and Microbiology1%
  • Health Professions0.7%
  • Environmental Science0.7%
  • Other2.6%

Topics

  • Parathyroid Disorders and Treatments18.1%
  • Dialysis and Renal Disease Management7.6%
  • Vitamin D Research Studies4.9%
  • Magnesium in Health and Disease4.3%
  • Bone health and osteoporosis research3.4%
  • Chronic Kidney Disease and Diabetes2.9%
  • Other58.8%

Coauthors

All papers

Open in search
  1. Executive summary of the 2017 KDIGO Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD) Guideline Update: what’s changed and why it matters

    Authors: , , , , , , , , , , , - Kidney International 2017 cited by 1,002

  2. Definition, evaluation, and classification of renal osteodystrophy: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO)

    Authors: , , , , , , , , , - Kidney International 2006 cited by 1,973

  3. Effect of Etelcalcetide vs Cinacalcet on Serum Parathyroid Hormone in Patients Receiving Hemodialysis With Secondary Hyperparathyroidism

    Authors: , , , , , , , , , , , , , , - JAMA 2017 cited by 304

  4. Diagnostic Accuracy of Bone Turnover Markers and Bone Histology in Patients With CKD Treated by Dialysis

    Authors: , , , , , , , , , , , - American Journal of Kidney Diseases 2015 cited by 304

  5. Vegetarian Compared with Meat Dietary Protein Source and Phosphorus Homeostasis in Chronic Kidney Disease

    Authors: , , , , , , , - Clinical Journal of the American Society of Nephrology 2010 cited by 573

  6. Mechanisms of Vascular Calcification in Chronic Kidney Disease

    Authors: , - Journal of the American Society of Nephrology 2007 cited by 573

  7. Matrix vesicles induce calcification of recipient vascular smooth muscle cells through multiple signaling pathways

    Authors: , , - Kidney International 2017 cited by 115

  8. Single‐cell RNAseq provides insight into altered immune cell populations in human fracture nonunions

    Authors: , , , , , , , , , , - Journal of Orthopaedic Research® 2022 cited by 33

  9. Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease–Mineral and Bone Disorder: Synopsis of the Kidney Disease: Improving Global Outcomes 2017 Clinical Practice Guideline Update

    Authors: , , , , , , , , , , , - Annals of Internal Medicine 2018 cited by 317

  10. Cinacalcet, Fibroblast Growth Factor-23, and Cardiovascular Disease in Hemodialysis

    Authors: , , , , , , , , , , , , , , - Circulation 2015 cited by 304

  11. Effects of Cinacalcet on Fracture Events in Patients Receiving Hemodialysis

    Authors: , , , , , , , , , , , , , - Journal of the American Society of Nephrology 2014 cited by 210

  12. Vascular Calcification: Pathophysiology and Risk Factors

    Authors: , - Current Hypertension Reports 2012 cited by 209

  13. The American Association of Endocrine Surgeons Guidelines for the Definitive Surgical Management of Secondary and Tertiary Renal Hyperparathyroidism

    Authors: , , , , , , , , , - Annals of Surgery 2022 cited by 110

  14. Cinacalcet for Secondary Hyperparathyroidism in Patients Receiving Hemodialysis

    Authors: , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2004 cited by 1,132

  15. High glucose increases the expression of Cbfa1 and BMP-2 and enhances the calcification of vascular smooth muscle cells

    Authors: , , , - Nephrology Dialysis Transplantation 2006 cited by 203

  16. Phosphate in Cardiovascular Disease: From New Insights Into Molecular Mechanisms to Clinical Implications

    Authors: , , , , , , , - Arteriosclerosis Thrombosis and Vascular Biology 2024 cited by 49

  17. Reciprocal innovation: A new approach to equitable and mutually beneficial global health partnerships

    Authors: , , , , , , , , , , , , , , , , , - Global Public Health 2022 cited by 53

  18. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Dick de Zeeuw, Thomas A. Golper, Frank A. Gotch, Antonio M. Gotto, Roger Greenwood, Joel Greer, Richard H. Grimm, William E. Haley, Ronald J. Hogg, Alan R. Hull, Lawrence G. Hunsicker, Cynda Ann Johnson, Michael J. Klag, Saulo Klahr, Norbert Lameire, Francesco Locatelli, Sally D. McCulloch, Maureen Michael, Joseph V. Nally, John M. Newmann, Allen R. Nissenson, Keith C. Norris, Gregorio T. Obrador, William F. Owen, Thakor G. Patel, Glenda M. Payne, Claudio Ronco, Rosa A. Rivera-Mizzoni, Anton C. Schoolwerth, Robert A. Star, Michael W. Steffes, Theodore I. Steinman, John Pierre Wauters, Nanette K. Wenger, Josephine P. Briggs, Thomas H. Hostetter, Garabed Eknoyan, Aderra Levin, Nathan W. Levin, Sharon Andreoli, S Burrows-Hudson, Derrick L. Latos, Donna Mapes, Edith T. Oberley, Brian J.G. Pereira, Nadine Ferguson, Donna Fingerhut, Anthony Gucciardo, Margaret Klette, Doreen Mallard, Kerry Willis - 2003 cited by 2,538

  19. EOS789, a broad-spectrum inhibitor of phosphate transport, is safe with an indication of efficacy in a phase 1b randomized crossover trial in hemodialysis patients

    Authors: , , , , , , , , , , , , - Kidney International 2020 cited by 42

  20. Pathophysiology of Vascular Calcification in Chronic Kidney Disease

    Authors: , - Circulation Research 2004 cited by 503

  21. Plant-Based Diets, the Gut Microbiota, and Trimethylamine N-Oxide Production in Chronic Kidney Disease: Therapeutic Potential and Methodological Considerations

    Authors: , , , , , - Journal of Renal Nutrition 2020 cited by 39

  22. The CALCIPHYX study: a randomized, double-blind, placebo-controlled, Phase 3 clinical trial of SNF472 for the treatment of calciphylaxis

    Authors: , , , , , , , , , , , , , , - Clinical Kidney Journal 2021 cited by 37

  23. Pharmacogenomics of Hypertension in CKD: The CKD-PGX Study

    Authors: , , , , , , , , , , , - Kidney360 2021 cited by 19

  24. Relationship between klotho and physical function in healthy aging

    Authors: , , , , , , , , - Scientific Reports 2023 cited by 18